The clinical value of regional lymphadenectomy for intrahepatic cholangiocarcinoma

被引:6
作者
Yang, Facai [1 ,2 ]
Wu, Changkang [3 ]
Bo, Zhiyuan [4 ]
Xu, Jian [3 ]
Yi, Bin [3 ]
Li, Jingdong [3 ]
Qiu, Yinghe [4 ]
机构
[1] Southeast Univ, Zhongda Hosp, Hepatopancreatobiliary Ctr, Sch Med, Nanjing 210009, Peoples R China
[2] North Sichuan Med Coll, Dept Hepatobiliary Surg, Affiliated Hosp, Nanchong 637000, Peoples R China
[3] North Sichuan Med Coll, Hepatobiliary & Intestine Res Inst, Affiliated Hosp, Dept Hepatobiliary Surg,Hepatobiliary & Pancreat, Nanchong 637000, Peoples R China
[4] Naval Mil Med Univ, Affiliated Hosp 3, Dept Biliary Surg, Shanghai 200438, Peoples R China
基金
中国国家自然科学基金;
关键词
Intrahepatic cholangiocarcinoma; N staging; Lymph node dissection; Lymph node metastasis; PROGNOSTIC-FACTORS; RESECTION; SURVIVAL; TRENDS;
D O I
10.1016/j.asjsur.2021.06.031
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: The aim of this study was to explore the clinical value of lymph node dissection (LND) for intrahepatic cholangiocarcinoma (ICC). Methods: Clinical and pathological data were collected from 147 ICC patients who attended two tertiary centers over the past 5 years. The patients were classified into two groups: the LND group (group A) and the no-performance LND (NLND) group (group B). Clinical and pathological parameters were compared between the two groups to analyze the impact of LND on the long-term survival time of ICC patients. Results: Of the 147 patients, 54.4% (80) received LND and 42.5% (34/80) of these were found to have lymph node metastasis (LNM). LND did not increase postoperative complications (27.5%, P = 0.354), but postoperative hospital stays were longer (12.2 +/- 6.3 d, P = 0.005) in group A compared with group B (20.9%, 9.5 +/- 3.5 d). The 5-year survival rates of groups A and B are almost similar (21% vs 29%, P = 0.905). The overall survival rate of cN0 (diagnosis obtained by imaging) is better than pN1 (diagnosis obtained by histopathology), but lower than pN0 (all P < 0.05). Compared with NLND, the median survival time of LND patients with T1 has not significantly improved (29.3 vs 35.1 months, P = 0.762), but the patients with T2-4 has been significantly increased (29.0 vs 17.1 months, P = 0.040). Elevated CA19-9 level (HR = 1.764, 95% CI: 1.113-2.795, P = 0.016), vascular invasion (HR = 2.697, 95% CI: 1.103-6.599, P = 0.030), and T category (HR =1.848, 95% CI: 1.059-3.224, P = 0.031) were independent risk factors for poor long-term survival time of the ICC patients (all P values < 0.05). Conclusion: ICC patients with cN0 may have LNM, and the long-term survival time of LNM patients is usually poor. We suggest that patients with ICC may require routine LND, especially those with T2-4 category. (c) 2021 Asian Surgical Association and Taiwan Robotic Surgery Association. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).
引用
收藏
页码:376 / 380
页数:5
相关论文
共 25 条
  • [1] Current survival and treatment trends for surgically resected intrahepatic cholangiocarcinoma in the United States
    Altman, Ariella M.
    Kizy, Scott
    Marmor, Schelomo
    Huang, Jing Li
    Denbo, Jason W.
    Jensen, Eric H.
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2018, 9 (05) : 942 - +
  • [2] Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
    Bridgewater, John
    Galle, Peter R.
    Khan, Shahid A.
    Llovet, Josep M.
    Park, Joong-Won
    Patel, Tushar
    Pawlik, Timothy M.
    Gores, Gregory J.
    [J]. JOURNAL OF HEPATOLOGY, 2014, 60 (06) : 1268 - 1289
  • [3] The Prognosis and Survival Outcome of Intrahepatic Cholangiocarcinoma Following Surgical Resection: Association of Lymph Node Metastasis and Lymph Node Dissection with Survival
    Choi, Sae-Byeol
    Kim, Kyung-Sik
    Choi, Jin-Young
    Park, Seung-Woo
    Choi, Jin-Sub
    Lee, Woo-Jung
    Chung, Jae-Bock
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (11) : 3048 - 3056
  • [4] Intrahepatic Cholangiocarcinoma: An International Multi-Institutional Analysis of Prognostic Factors and Lymph Node Assessment
    de Jong, Mechteld C.
    Nathan, Hari
    Sotiropoulos, Georgios C.
    Paul, Andreas
    Alexandrescu, Sorin
    Marques, Hugo
    Pulitano, Carlo
    Barroso, Eduardo
    Clary, Bryan M.
    Aldrighetti, Luca
    Ferrone, Cristina R.
    Zhu, Andrew X.
    Bauer, Todd W.
    Walters, Dustin M.
    Gamblin, T. Clark
    Nguyen, Kevin T.
    Turley, Ryan
    Popescu, Irinel
    Hubert, Catherine
    Meyer, Stephanie
    Schulick, Richard D.
    Choti, Michael A.
    Gigot, Jean-Francois
    Mentha, Gilles
    Pawlik, Timothy M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (23) : 3140 - 3145
  • [5] Intrahepatic Cholangiocarcinoma
    El-Diwany, Ramy
    Pawlik, Timothy M.
    Ejaz, Aslam
    [J]. SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2019, 28 (04) : 587 - +
  • [6] Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012
    Florio, Andrea A.
    Ferlay, Jacques
    Znaor, Ariana
    Ruggieri, David
    Alvarez, Christian S.
    Laversanne, Mathieu
    Bray, Freddie
    McGlynn, Katherine A.
    Petrick, Jessica L.
    [J]. CANCER, 2020, 126 (11) : 2666 - 2678
  • [7] Intrahepatic cholangiocarcinoma patients without indications of lymph node metastasis not benefit from lymph node dissection
    Hu, Jie
    Chen, Fei-Yu
    Zhou, Kai-Qian
    Zhou, Cheng
    Cao, Ya
    Sun, Hui-Chuan
    Fan, Jia
    Zhou, Jian
    Wang, Zheng
    [J]. ONCOTARGET, 2017, 8 (69) : 113817 - 113827
  • [8] Is there a role for systematic hepatic pedicle lymphadenectomy in intrahepatic cholangiocarcinoma? A review of 17 years of experience in a tertiary institution
    Kim, Dong Hun
    Choi, Dong Wook
    Choi, Seong Ho
    Heo, Jin Seok
    Kow, Alfred Wei-Chieh
    [J]. SURGERY, 2015, 157 (04) : 666 - 675
  • [9] Oncologic Impact of Lymph Node Dissection for Intrahepatic Cholangiocarcinoma: a Propensity Score-Matched Study
    Kim, Sung Hyun
    Han, Dai Hoon
    Choi, Gi Hong
    Choi, Jin Sub
    Kim, Kyung Sik
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2019, 23 (03) : 538 - 544
  • [10] Report of the 20th Nationwide follow-up survey of primary liver cancer in Japan
    Kudo, Masatoshi
    Izumi, Namiki
    Kubo, Shoji
    Kokudo, Norihiro
    Sakamoto, Michiie
    Shiina, Shuichiro
    Tateishi, Ryosuke
    Nakashima, Osamu
    Murakami, Takamichi
    Matsuyama, Yutaka
    Takahashi, Arata
    Miyata, Hiroaki
    Takayama, Tadatoshi
    [J]. HEPATOLOGY RESEARCH, 2020, 50 (01) : 15 - 46